When was ProteinSimple founded?

ProteinSimple was founded in 2004 and raised its 1st funding round 2 years after it was founded.

Where is ProteinSimple located?

ProteinSimple is headquartered in San Jose, United States.

How many employees does ProteinSimple have?

As of Jun 30, 2026, the latest employee count at ProteinSimple is 183.

Is ProteinSimple a funded company?

ProteinSimple is a funded company, having raised a total of $94.3M across 6 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on Nov 2006.

When was the latest funding round of ProteinSimple?

ProteinSimple's latest funding was a $***** Series F round on May 11, 2011, with participation from 0 investor.

Where does ProteinSimple rank among its competitors?

ProteinSimple ranks 18th amongst 305 active competitors, of which 73 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Unnatural Products, which secured $45M in Mar, 2026.

Who are the top competitors of ProteinSimple?

ProteinSimple's top competitors include Seer, Nautilus Biotechnology and Somalogic. Among them, Unnatural Products secured the most recent funding round in March, 2026.

ProteinSimple - 2026 Company Profile, Team, Funding & Competitors

Q: Is ProteinSimple an acquired company?

ProteinSimple got acquired by Bio-Techne on Jun 17, 2014.

Company Details

Provider tools to help researchers with protein analysis. It offers Simple Plex Assays, multi-analyte immunoassays for biomarker research, Micro-Flow Imaging (MFI), a solution for aggregate and particle analysis, as well as monitoring and characterizing aggregates during the formulation development process, and AlphaImager gel documentation systems that provide imaging for a range of UV fluorescent and colorimetric applications. The company also provides Simple Western Assays that provide quantitative protein characterization and protein analysis in precious samples and an iCE System that measures protein purity, charges heterogeneity protein analysis, evaluates formulation development, and screens cell lines.

Website: proteinsimple.com
Social
Part Of

Key Metrics

Founded Year

2004

Location

San Jose, United States

Stage

Acquired

Total Funding

$94.3M in 6 rounds

Latest Funding Round

Series F, May 11, 2011, $*****

Investors

Royal Bank of Canada & 11 more

Ranked

18^th among 305 active competitors

Employee Count

183 as on Jun 30, 2026

Similar Companies

Seer & 396 more

Exit Details

Acquired by Bio-Techne (Jun 17, 2014)

View ProteinSimple's full profile

ProteinSimple is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Bio-techne Corporation CIN: 41-1427402 , United States, Active	Dec 31, 2003	-	2400 (As on Jun 30, 2023)	-

ProteinSimple got acquired by Bio-Techne on Jun 17, 2014 at an acquisition amount of $*****.

Click here to take a look at ProteinSimple's acquisition in detail

ProteinSimple has raised a total funding of $94.3M over 6 rounds. Its first funding round was on Nov 2006. ProteinSimple has 12 institutional investors.

Here is the list of recent funding rounds of ProteinSimple:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 11, 2011	3226781	Series F	9932322	5114243	9371618	3533798
Oct 14, 2010	2820592	Series F	4225044	1751934	3364656	Domain Associates & 6 more
Dec 04, 2009	3190648	Series D	5038865	1690651	3735666	Novo Holdings

Access funding benchmarks and valuations. Sign up today!

View details of ProteinSimple's funding rounds and investors

The founders of ProteinSimple is David Voehringer.

Here are the details of ProteinSimple's key team members:

David Voehringer: Former Co-Founder of ProteinSimple.

View details of ProteinSimple's Founder profiles and Board Members

ProteinSimple's employee count trend

ProteinSimple has 183 employees as of Jun 26. Here is ProteinSimple's employee count trend over the years:

Uncover ProteinSimple's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ProteinSimple include Seer, Nautilus Biotechnology and Somalogic. Here is the list of Top 10 competitors of ProteinSimple, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Seer 2017, San Francisco (United States), Public	Developer of proteomics platform for early detection of cancer and neurological diseases	$128M	aMoon, Fidelity Investments & 15 others	72/100
2nd	Nautilus Biotechnology 2016, Seattle (United States), Public	Developer of proteomics platform for drug development	$453M	Vulcan, Bain Capital Life Sciences & 8 others	65/100
3rd	Somalogic 1999, Boulder (United States), Acquired	Developer of protein-based assays for life science research	$664M	ProQuest Investments, ICarbonX & 27 others	64/100
4th	Biognosys 2008, Schlieren (Switzerland), Acquired	Provider of proteomics service	$9.13M	Zurcher Kantonalbank, Syngenta Group & 6 others	63/100
5th	Peptris 2019, Bengaluru (India), Series A	Provider of AI-based proteomic data analysis software for drug discovery	$9.17M	Speciale Invest, Indian Angel Network Fund ... & 46 others	60/100
6th	Peptone 2016, Amsterdam (Netherlands), Series A	Provider of an AI based protein analysis platform for research and development	$42.5M	F-Prime Capital, Bessemer Venture Partners ... & 6 others	60/100
7th	Talus 2020, Seattle (United States), Seed	Provider of drug discovery platform for gene regulators	$19.8M	Fifty Years, Y Combinator & 11 others	60/100
8th	Arzeda 2008, Seattle (United States), Series B	Developer of enzyme design technology to bridge the gap by creating synthetic enzymes	$95.2M	OS Fund, Conti Ventures & 22 others	58/100
9th	Unnatural Products 2016, Santa Cruz (United States), Series B	Developer of computational biology techniques platform to engineer peptides for undruggable targets	$83M	Merck Global Health Innovation Fund, Artis Ventures ... & 17 others	58/100
10th	Amunix 2006, Mountain View (United States), Acquired	Developer of peptide-based therapeutics	$201M	Omega Funds, Viking Global Investors & 18 others	57/100
18th	ProteinSimple 2004, San Jose (United States), Acquired	Provider tools to help researchers with protein analysis	$94.3M	Royal Bank of Canada, Novo Holdings & 10 others	54/100